ArticleAMB Express2025
Effects of Pediococcus acidilactici on growth, blood physiology, health and gene expression in red tilapia.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Invisible Balance: How Prebiotics and Probiotics Can Support Fish Health and Development.Life (Basel, Switzerland) · 2026Review
- Probiotic Effects of Marichromatium gracile DH-1 on Growth, Stress Resistance, and Water Quality in Juvenile Seahorses: A Potential Strategy for Sustainable Aquaculture.Probiotics and antimicrobial proteins · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the widespread practice of using probiotics in aquaculture for their potential benefits, the consistency of their impact on disease resistance in fish is still being scrutinized. This study aimed to address this gap by investigating the influence of the probiotic Pediococcus acidilactici (PCA) on hematological indices, body composition, serum metabolites, water quality, growth metrics, the transcriptomic profile of genes related to immune function, and the ability of red tilapia (Oreochromis niloticus × O. mossambicus) to resist challenge with the bacterial pathogen Aeromonas hydrophila. A total of 180 tilapia fingerlings (average weight 17.10 ± 0.46 g) were distributed into four groups and fed a basal diet supplemented with 0 (PCA0), 1 (PCA1), 2 (PCA2), and 3 (PCA3) g of PCA per kg of diet for 63 days. Water quality analysis indicated a significant decrease in both salinity and dissolved oxygen concentrations in all PCA-supplemented groups compared to a PCA-free diet (P < 0.05). Fish fed diets having 2 or 3 PCA had superior FBW, SGR, and ADG, while these levels significantly improved the FCR compared to the untreated diet (P < 0.001). In fish supplemented with PCA, body composition analysis showed a statistically significant increase in protein and ash content, accompanied by a statistically significant decrease in lipid content (P < 0.05). Furthermore, dietary PCA significantly enhanced phagocytic index, and serum IgG and IgM levels in a dose-dependent response. Notable improvements in hematological variables and blood protein fractions were observed in the PCA2 and PCA3 groups compared to other groups (P < 0.05). Dietary PCA administration sustained liver enzymes and kidney functions (P < 0.05). Dietary supplementation with PCA resulted in a significant upregulation (P < 0.05) of growth-related genes (GH, IGF-1, and IGF1-R) and immunity-associated genes (CXC chemokine, IL8, and IL1β) in a dose-dependent manner. Furthermore, dietary PCA improved the histological structure of the liver and enhanced intestinal integrity in Tilapia. Following pathogen challenge, the survival rate was significantly higher in all PCA-supplemented groups compared to the control group, with the highest survival observed in the PCA3 group. In summary, this research highlights the significant benefits of dietary Pediococcus acidilactici supplementation at 2 and 3 g/kg for improving growth, blood physiology, immunity, and disease resistance in red tilapia. These findings underscore the potential of Pediococcus acidilactici as a practical and effective strategy for enhancing productivity and sustainability in red tilapia aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.